Impact of Chronic Kidney Disease on Postinfarction Inflammation, Oxidative Stress, and Left Ventricular Remodeling

Journal of Cardiac Failure

Volumn 14, Issue 10, 2008, Pages 831-838

  Naito, Kotaro ^a   Anzai, Toshihisa ^a   Yoshikawa, Tsutomu ^a   Anzai, Atsushi ^a   Kaneko, Hidehiro ^a   Kohno, Takashi ^a   Takahashi, Toshiyuki ^a   Kawamura, Akio ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; chronic kidney disease; inflammation; oxidative stress

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HEART VENTRICLE VOLUME; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RISK FACTORS; VENTRICULAR REMODELING;

EID: 56449086727     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.07.233     Document Type: Article

References (52)

1. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (1998) S112-S119
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Best P.J., Reddan D.N., Berger P.B., Szczech L.A., McCullough P.A., and Califf R.M. Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J 148 (2004) 230-242
4. Tonelli M., Wiebe N., Culleton B., House A., Rabbat C., Fok M., et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17 (2006) 2034-2047
5. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
6. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
7. Tokmakova M.P., Skali H., Kenchaiah S., Braunwald E., Rouleau J.L., Packer M., et al. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation 110 (2004) 3667-3673
8. Schiele F., Legalery P., Didier K., Meneveau N., Seronde M.F., Caulfield F., et al. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. Am Heart J 151 (2006) 661-667
9. Marenzi G., Moltrasio M., Assanelli E., Lauri G., Marana I., Grazi M., et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 153 (2007) 755-762
10. Wright R.S., Reeder G.S., Herzog C.A., Albright R.C., Williams B.A., Dvorak D.L., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137 (2002) 563-570
11. Berger A.K., Duval S., and Krumholz H.M. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42 (2003) 201-208
12. Naito K., Anzai T., Yoshikawa T., Maekawa Y., Sugano Y., Kohno T., et al. Increased body temperature after reperfused acute myocardial infarction is associated with adverse left ventricular remodeling. J Card Fail 13 (2007) 25-33
13. Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
14. Takahashi T., Anzai T., Yoshikawa T., Maekawa Y., Asakura Y., Satoh T., et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction-role of neurohormones and cytokines. Int J Cardiol 88 (2003) 257-265
15. Maekawa Y., Anzai T., Yoshikawa T., Asakura Y., Takahashi T., Ishikawa S., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 39 (2002) 241-246
16. Shlipak M.G., Fried L.F., Crump C., Bleyer A.J., Manolio T.A., Tracy R.P., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107 (2003) 87-92
17. Goicoechea M., de Vinuesa S.G., Lahera V., Cachofeiro V., Gomez-Campdera F., Vega A., et al. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) S231-S235
18. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
19. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Hara S., et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 11 (2007) 41-50
20. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
21. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
22. Shiraki H., Yoshikawa T., Anzai T., Negishi K., Takahashi T., Asakura Y., et al. Association between preinfarction angina and a lower risk of right ventricular infarction. N Engl J Med 338 (1998) 941-947
23. Killip III T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
24. Forrester J.S., Diamond G., Chatterjee K., and Swan H.J. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med 295 (1976) 1356-1362
25. Sosnov J., Lessard D., Goldberg R.J., Yarzebski J., and Gore J.M. Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective. Am J Kidney Dis 47 (2006) 378-384
26. Charytan D., and Kuntz R.E. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 70 (2006) 2021-2030
27. Koomans H.A., Blankestijn P.J., and Joles J.A. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15 (2004) 524-537
28. Bongartz L.G., Cramer M.J., Doevendans P.A., Joles J.A., and Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 26 (2005) 11-17
29. Szabo B., Hedler L., Schurr C., and Starke K. Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits. J Cardiovasc Pharmacol 15 (1990) 968-975
30. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20 (1992) 248-254
31. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
32. Ruiz-Ortega M., Lorenzo O., and Egido J. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells. Kidney Int 57 (2000) 2285-2298
33. Amin J.K., Xiao L., Pimental D.R., Pagano P.J., Singh K., Sawyer D.B., et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33 (2001) 131-139
34. Oddis C.V., Simmons R.L., Hattler B.G., and Finkel M.S. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Ame J Physiol Heart Circ Physiol 269 (1995) H2044-H2050
35. Prabhu S.D., Chandrasekar B., Murray D.R., and Freeman G.L. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101 (2000) 2103-2109
36. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
37. Owen W.F., and Lowrie E.G. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54 (1998) 627-636
38. Bologa R.M., Levine D.M., Parker T.S., Cheigh J.S., Serur D., Stenzel K.H., et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 (1998) 107-114
39. Schouten W.E., Grooteman M.P., van Houte A.J., Schoorl M., van Limbeek J., and Nube M.J. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 15 (2000) 379-384
40. Schwedler S., Schinzel R., Vaith P., and Wanner C. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?. Kidney Int 78 (2001) S32-S36
41. Arstall M.A., Sawyer D.B., Fukazawa R., and Kelly R.A. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85 (1999) 829-840
42. MacLellan W.R., and Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81 (1997) 137-144
43. Sivasubramanian N., Coker M.L., Kurrelmeyer K.M., MacLellan W.R., DeMayo F.J., Spinale F.G., et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104 (2001) 826-831
44. Li Y.Y., Feng Y.Q., Kadokami T., McTiernan C.F., Draviam R., Watkins S.C., et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 97 (2000) 12746-12751
45. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14 (2003) 2534-2543
46. Malyszko J., Bachorzewska-Gajewska H., Malyszko J.S., Pawlak K., and Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 13 (2008) 153-156
47. Mishra J., Mori K., Ma Q., Kelly C., Yang J., Mitsnefes M., et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15 (2004) 3073-3082
48. Lesnefsky E.J., Lundergan C.F., Hodgson J.M., Nair R., Reiner J.S., Greenhouse S.W., et al. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J Am Coll Cardiol 28 (1996) 331-337
49. Liu P., Xu B., Cavalieri T.A., and Hock C.E. Age-related difference in myocardial function and inflammation in a rat model of myocardial ischemia-reperfusion. Cardiovasc Res 56 (2002) 443-453
50. Mahara K., Anzai T., Yoshikawa T., Maekawa Y., Okabe T., Asakura Y., et al. Aging adversely affects postinfarction inflammatory response and early left ventricular remodeling after reperfused acute anterior myocardial infarction. Cardiology 105 (2006) 67-74
51. McCullough P.A., Li S., Jurkovitz C.T., Stevens L.A., Wang C., Collins A.J., et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51 (2008) S38-S45
52. Parikh C.R., Coca S.G., Wang Y., Masoudi F.A., and Krumholz H.M. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 168 (2008) 987-995